Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACETADOTE | Cumberland Pharmaceuticals | N-021539 RX | 2004-01-23 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MUCOMYST W/ ISOPROTERENOL | Mead Johnson Nutrition | N-017366 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
acetadote | New Drug Application | 2023-01-27 |
acetylcysteine | ANDA | 2023-11-08 |
premasol - sulfite-free (amino acid) | ANDA | 2022-08-04 |
trophamine | New Drug Application | 2022-08-22 |
Code | Description |
---|---|
J0132 | Injection, acetylcysteine, 100 mg |
J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram |
J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Oxidative stress | D018384 | EFO_1001905 | — | 4 | 5 | 3 | 1 | 6 | 18 |
Chronic renal insufficiency | D051436 | — | N18 | 1 | 3 | 7 | 1 | 3 | 14 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | 2 | 3 | 3 | 6 | 14 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 2 | 5 | 5 | 12 |
Alcoholism | D000437 | EFO_0003829 | F10.1 | 3 | 8 | — | 2 | — | 12 |
Cocaine-related disorders | D019970 | — | F14 | 5 | 4 | — | 1 | 1 | 11 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 1 | 2 | 2 | 4 | 3 | 11 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 1 | 4 | — | 3 | 1 | 9 |
Schizophrenia | D012559 | EFO_0000692 | F20 | 3 | 3 | — | 2 | 1 | 8 |
Hypertension | D006973 | EFO_0000537 | I10 | 2 | — | — | 3 | 2 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | 9 | 8 | 4 | — | 3 | 21 |
Healthy volunteers/patients | — | — | — | 7 | — | 1 | — | 4 | 12 |
Chemical and drug induced liver injury | D056486 | EFO_0004228 | — | 1 | 3 | 2 | — | 3 | 7 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 2 | 4 | 1 | — | 1 | 6 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 1 | 2 | — | 2 | 5 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 4 | 2 | — | 1 | 5 |
Bronchiectasis | D001987 | HP_0002110 | J47 | — | — | 1 | — | 3 | 4 |
Retinitis pigmentosa | D012174 | HP_0000580 | H35.52 | 2 | 1 | 1 | — | — | 4 |
Inflammation | D007249 | MP_0001845 | — | 2 | 1 | 1 | — | 1 | 4 |
Diabetic foot | D017719 | EFO_1001459 | — | — | — | 1 | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Parkinson disease | D010300 | EFO_0002508 | G20 | 3 | 4 | — | — | 3 | 9 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | 4 | 5 | — | — | 3 | 9 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | 3 | — | — | 2 | 6 |
Obesity | D009765 | EFO_0001073 | E66.9 | 2 | 1 | — | — | 4 | 6 |
Liver failure | D017093 | HP_0001399 | K72.9 | — | 3 | — | — | 2 | 5 |
Aging | D000375 | GO_0007568 | R41.81 | 3 | 2 | — | — | — | 4 |
Proteinuria | D011507 | HP_0000093 | R80 | — | 2 | — | — | 2 | 4 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 2 | — | — | 1 | 4 |
Traumatic brain injuries | D000070642 | — | S06 | 1 | 3 | — | — | 1 | 4 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | 4 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | — | — | — | 1 | 3 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | 1 | 2 |
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | 1 | — | — | — | 1 | 2 |
Diabetic retinopathy | D003930 | EFO_0003770 | — | 1 | — | — | — | 1 | 2 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | 1 | — | — | — | 1 | 2 |
Severe acute respiratory syndrome | D045169 | EFO_0000694 | J12.81 | 1 | — | — | — | — | 1 |
Immunoglobulin light-chain amyloidosis | D000075363 | — | — | 1 | — | — | — | — | 1 |
Ovarian epithelial carcinoma | D000077216 | — | — | 1 | — | — | — | — | 1 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
Amyotrophic lateral sclerosis | D000690 | HP_0007354 | G12.21 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Eye diseases | D005128 | EFO_0003966 | H44 | — | — | — | — | 4 | 4 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | — | — | — | 3 | 3 |
Vascular dementia | D015140 | — | F01 | — | — | — | — | 2 | 2 |
Male infertility | D007248 | EFO_0004248 | N46 | — | — | — | — | 2 | 2 |
Humans | D006801 | — | STY/T016 | — | — | — | — | 2 | 2 |
Culture media | D003470 | — | — | — | — | — | — | 2 | 2 |
Blastocystis | D016844 | — | — | — | — | — | — | 2 | 2 |
Lewy body disease | D020961 | EFO_0006792 | G31.83 | — | — | — | — | 1 | 1 |
Neurodegenerative diseases | D019636 | EFO_0005772 | G31.9 | — | — | — | — | 1 | 1 |
Hyperhomocysteinemia | D020138 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Acetylcysteine |
INN | acetylcysteine |
Description | N-acetyl-L-cysteine is an N-acetyl-L-amino acid that is the N-acetylated derivative of the natural amino acid L-cysteine. It has a role as an antiinfective agent, an antioxidant, an antiviral drug, an antidote to paracetamol poisoning, a vulnerary, a mucolytic, a human metabolite, a radical scavenger, a ferroptosis inhibitor and a geroprotector. It is a L-cysteine derivative, an acetylcysteine and a N-acetyl-L-amino acid. It is a conjugate acid of a N-acetyl-L-cysteinate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)N[C@@H](CS)C(=O)O |
PDB | — |
CAS-ID | 616-91-1 |
RxCUI | — |
ChEMBL ID | CHEMBL600 |
ChEBI ID | 28939 |
PubChem CID | 12035 |
DrugBank | DB06151 |
UNII ID | WYQ7N0BPYC (ChemIDplus, GSRS) |